Benzinga's Volume Movers

Marvell Technology Group Ltd. MRVL shares rose 10.81 percent to $10.66. The volume of Marvell Technology shares traded was 495 percent higher than normal. Marvell reported senior leadership transition. Marvell Technology announced that its CEO Sehat Sutardja and President Weili Dai will leave the company effective immediately. Intercept Pharmaceuticals Inc ICPT shares moved up 16.66 percent to $155.80. The volume of Intercept Pharmaceuticals traded was 251 percent higher than normal. Intercept Pharmaceuticals shares surged as investors found the U.S. Food and Drug Administration's latest briefing documents to be encouraging. The FDA has a scheduled advisory committee meeting on Thursday and will discuss the new drug application 20799, obeticholic acid oral tablets, submitted by Intercept Pharmaceuticals for the treatment of primary biliary cirrhosis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. Valeant Pharmaceuticals Intl Inc VRX shares climbed 8.62 percent to $28.35. The volume of Valeant Pharmaceuticals shares traded was 495 percent higher than normal. Valeant announced that an ad hoc committee of the board of directors concluded its review of various Philidor and related account matters. The committee stated it has not identified any additional items that would require restatements beyond what has already been disclosed. Smith & Wesson Holding Corp SWHC surged 3.45 percent to $23.57. The volume of Smith & Wesson shares traded was 60 percent higher than normal. Smith & Wesson shares have surged 74.83 percent over the past 52 weeks, while the S&P 500 index has slipped 0.49 percent in the same period.